• SENSEX 72,529.07
    -242.65 (--0.33%)
  • BANKNIFTY 54,259.95
    -211.70 (--0.39%)
  • Cube Highways
    156.41 162.00(%)
  • NSE
    1,793.70 1,878.00(%)
  • 360 ONE
    1,019.75 906.20(%)
  • SS Retail
    775.00 888.00(%)
  • Cupid
    292.35 298.95(%)
  • R Systems Intl.
    305.25 446.55(%)
  • GE Vernova T&D
    4,225.00 5,650.00(%)
  • Lords Mark Industries
    84.89 60.00(%)
  • PB Fintech.
    1,076.35 1,076.35(%)
  • Azad Engineering
    2,997.65 2,997.65(%)
  • Hero Motors
    140.75 156.03(%)
  • HDFC Bank
    720.00 1,020.35(%)
  • Reliance Industries
    1,182.05 1,182.05(%)
  • Delhivery
    418.15 524.25(%)
  • Ather Energy
    1,404.00 542.20(%)
  • Varmora Granito
    163.45 163.45(%)
  • Bharti Airtel
    1,788.00 2,174.70(%)
  • Indian Hotels Co
    725.50 757.10(%)
  • ICICI Lombard
    1,498.00 1,423.95(%)
  • Bajaj Finance
    961.65 788.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Astal Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4277.0
  • ISIN : INE307N01014
69.65 -1 (-1.92%)
  • As on 29 Sep 2026 (EOD)

  • Today’s Low

    69.52

  • Today’s High

    71.50

  • Open

    71.25

  • Perv Close

    71.01

  • 52W Low

    60.45

  • 52W High

    103.20

Key Indicators

  • P/E(TTM)

    31.37

  • Mar.Cap (₹Cr.)

    305.06

  • Div & Yield %

    0.00

  • Book Value(₹)

    75.67

  • Debt-Equity Ratio

    -1.92

  • AGM Date

    29-Sep-2026

  • EPS

    2.22

  • P/E Ratio

    31.37

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    305.06

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    43.80

  • BV (₹)

    75.70

  • Sales( ₹ in Cr.)

    156.00

  • NP (in Cr.)

    8.12

  • NP Var(%)

    -9.0

  • Div%

    0.0

  • CPS (₹)

    2.00

  • EPS (₹)

    1.90

  • Traded Value (₹ in Lakhs)

    305.06

  • 52 Week High

    103.20

  • 52 Week Low

    60.45

  • Price BSE

    70.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    305.06

  • P/C Ratio

    34.80

  • P/E Ratio

    37.80

  • Price Vs.BV

    1.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 156.00 64.23 23.65 3.43 0.00 0.20
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 156.00 64.23 23.65 3.43 0.00 0.20
Other Income 0.19 0.13 0.01 0.18 0.21 0.00
Stock Adjustments 14.02 13.70 1.06 0.00 0.00 0.00
Total Income 170.21 78.06 24.72 3.61 0.21 0.20
EXPENDITURE :            
Raw Materials 152.88 61.81 22.40 3.35 0.00 0.00
Power and Fuel Cost 0.28 0.14 0.02 0.01 0.02 0.01
Employee Cost 2.12 1.26 0.47 0.06 0.09 0.06
Other Manufacturing Expenses 0.25 0.37 0.00 0.01 0.01 0.01
Selling and Administration Expenses 1.70 1.57 0.71 0.13 0.10 0.10
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.01 0.00
Employee Benefit Expenses 2.12 1.26 0.47 0.06 0.09 0.06
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 157.23 65.15 23.59 3.56 0.21 0.18
Operating Profit 12.96 12.90 1.13 0.04 0.00 0.02
Interest 1.41 0.70 0.01 0.00 0.00 0.00
Gross Profit 11.55 12.20 1.12 0.04 0.00 0.02
Depreciation 0.69 0.22 0.03 0.01 0.01 0.02
Profit Before Tax 10.86 11.98 1.09 0.03 -0.01 0.00
Current Tax 2.59 2.94 0.29 0.01 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.16 0.11 0.01 0.01 0.00 0.00
Reported Net Profit 8.12 8.93 0.78 0.02 -0.02 0.01
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 8.12 8.93 0.78 0.02 -0.02 0.01
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 10.70 1.78 0.99 0.98 0.99 0.99
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 18.82 10.70 1.78 0.99 0.98 0.99
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.92 9.07 0.80 0.04 -0.04 0.02
Earnings Per Share(Adj)-Unit Curr 1.92 9.07 0.80 0.04 -0.04 0.02
Book Value 76.98 32.77 23.71 12.98 12.93 12.97
Book Value(Adj)-Unit Curr 76.98 32.77 23.71 12.98 12.93 12.97

Shareholding Pattern

  • Promoter Group

    4.53%

  • Public Share Holding

    95.47%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,985,595 4.53 1,985,595 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,985,595 4.53 1,985,595 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,221,917 2.79 1,184,717 27
Clearing Members 2,000 0.00 2,000 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 4,148,233 9.47 4,148,233 37
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 733,310 1.67 733,310 49
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 32,346,625 73.85 32,346,625 162
Individuals holding nominal share capital up to Rs. 1 lakh 3,076,318 7.02 2,712,098 2,992
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 41,813,337 95.47 41,411,917 3,273
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 43,798,932 100.00 43,397,512 3,274

Company Background

Astal Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Astal Laboratories Ltd
  • BSE Code : 4277.0
  • ISIN : INE307N01014

  • Incorporation Year

    1993

  • Registered Office

    House No 4-50/1 Sy No 134 132
    Block B 8th Floor Flat No 801, Hyderabad,
    Telangana-500032

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Mahendra Kumar

  • Auditor

    Sathuluri & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.&Computer Ser.P Ltd
    99 BeetalHouse 3rd F,
    Behind Local Shp Cen,Nr Dada Harsukh Das
    Mumbai - New Delhi - 110062

Astal Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Astal Lab 69.65 156.19 156.00 31.37 6.31
Abbott India 27,266.65 7,217.19 6,929.05 35.88 43.78
Astrazeneca Phar 6,254.35 2,304.07 2,275.58 92.18 27.86
Glaxosmi. Pharma 2,787.25 3,932.76 3,790.20 44.52 58.17
Novartis India 1,933.35 393.10 354.33 48.82 15.94
Cipla 1,383.00 20,102.60 18,979.95 36.35 13.88
Bliss GVS Pharma 710.05 773.53 729.81 65.99 12.51
Fermenta Biotec. 549.30 474.15 450.25 25.64 18.77
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Guj. Themis Bio. 404.40 168.25 165.82 108.13 18.05
Ambalal Sarabhai 39.24 19.52 3.94 72.67 6.77